Form 8-K - Current report:
SEC Accession No. 0001021771-25-000148
Filing Date
2025-11-12
Accepted
2025-11-12 16:11:57
Documents
17
Period of Report
2025-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THIRD QUARTER 2025 FINANCIAL RESULTS brt8k.htm   iXBRL 8-K 26826
2 PRESS RELEASE ex99_1.htm EX-99.1 1794
6 brtpr_1.jpg GRAPHIC 825074
7 brtpr_2.jpg GRAPHIC 903361
8 brtpr_3.jpg GRAPHIC 1109695
9 brtpr_4.jpg GRAPHIC 490048
  Complete submission text file 0001021771-25-000148.txt   4737870

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brtx-20251112.xsd EX-101.SCH 3884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20251112_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20251112_pre.xml EX-101.PRE 16057
19 EXTRACTED XBRL INSTANCE DOCUMENT brt8k_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 251472842
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)